Crohn's disease following rituximab treatment for follicular lymphoma in a patient with synchronous gastric signet ring cells carcinoma: A case report and literature review

Research output: Contribution to journalArticlepeer-review

Abstract

Recently, there have been a few reports of rituximab (RTX)-induced Crohn's disease, but there is no literature available on successful long-term treatment and the clinical outcome of this condition. We retrospectively analyzed the clinical data of a rare case of Crohn's disease induced by RTX administered as induction and prolonged maintenance therapy of a follicular lymphoma, diagnosed synchronously with a gastric signet ring cells carcinoma, treated at our hospital.

Original languageEnglish
Pages (from-to)1291-1295
Number of pages5
JournalCancer Research and Treatment
Volume52
Issue number4
DOIs
Publication statusPublished - Oct 2020

Keywords

  • Crohn's disease
  • Gastric signet ring cells carcinoma
  • Lymphoma
  • Rituximab

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Crohn's disease following rituximab treatment for follicular lymphoma in a patient with synchronous gastric signet ring cells carcinoma: A case report and literature review'. Together they form a unique fingerprint.

Cite this